Tesamorelin 10mg – Research Compound
Tesamorelin 10mg
Synthetic Peptide – Laboratory Research Compound
Tesamorelin is a synthetic peptide supplied for scientific and laboratory research applications.
It is structurally related to growth hormone–releasing hormone (GHRH) and is commonly studied
within controlled laboratory environments investigating peptide receptor signalling pathways
and endocrine regulatory mechanisms.
In experimental models, Tesamorelin has been investigated for its interaction with receptors
associated with peptide-mediated signalling processes. Due to its specific molecular structure,
the compound is of interest to researchers studying endocrine receptor activity, peptide
signalling pathways, and regulatory mechanisms involved in metabolic and hormonal research models.
Tesamorelin belongs to a class of investigational peptides designed to mimic naturally occurring
signalling molecules involved in complex biological communication systems. These compounds are
commonly utilised in laboratory research exploring receptor interactions and peptide-based
signalling processes.
Regenexis provides Tesamorelin in lyophilised (freeze-dried) powder form to help maintain
molecular stability and structural integrity during storage and transport. Lyophilisation
allows the peptide to remain stable until preparation for controlled laboratory analysis
or experimental use according to established research protocols.
Each vial is manufactured using controlled peptide synthesis techniques and undergoes
quality verification procedures designed to support purity, structural consistency,
and reliability for scientific research applications.
Research Areas
Tesamorelin is commonly explored in laboratory investigations relating to:
• Peptide receptor signalling pathways
• Endocrine system research models
• Metabolic signalling mechanisms
• Experimental peptide pharmacology
• Regulatory hormone pathway research
These areas of research continue to evolve as scientists investigate the complex biological
systems associated with peptide-mediated receptor signalling.
Product Quality
Regenexis research compounds are manufactured using controlled peptide synthesis techniques
designed to support high purity and consistent molecular structure. Each batch is produced
under strict laboratory manufacturing protocols to ensure quality and analytical reliability
suitable for scientific research environments.
Storage Guidelines
To maintain compound stability:
• Store lyophilised peptide powder at −20°C prior to use
• Protect from heat, moisture, and direct light
• Once prepared for laboratory use, maintain refrigerated storage and follow appropriate
laboratory handling procedures
Proper storage conditions help preserve peptide integrity for experimental and analytical research.
Important Notice
This product is supplied strictly for laboratory research purposes only.
Tesamorelin provided by Regenexis is not a therapeutic good and has not been evaluated
or approved by the Therapeutic Goods Administration (TGA) for human or veterinary use.
This compound must only be handled by qualified research professionals familiar with the
safe handling of research chemicals and peptides.
Regenexis products are not intended to diagnose, treat, cure, or prevent any disease and
must not be used for clinical or medical applications.
Technical Specifications
Technical Specifications
Compound Name: Tesamorelin
CAS Number: 218949-48-5
Peptide Class: Synthetic Peptide Research Compound
Molecular Formula: C221H366N72O67S
Molecular Weight: 5135.9 g/mol
Purity: ≥99% (HPLC)
Quantity: 10 mg per vial
Appearance: White lyophilised powder
Storage: −20°C recommended
Application: Laboratory research use only